Daniel B. Soland - Jan 24, 2022 Form 4 Insider Report for IDERA PHARMACEUTICALS, INC. (IDRA)

Signature
/s/ Daniel B. Soland
Stock symbol
IDRA
Transactions as of
Jan 24, 2022
Transactions value $
$0
Form type
4
Date filed
1/26/2022, 07:42 PM
Previous filing
Oct 1, 2021
Next filing
Apr 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDRA Stock Option (Right to Buy) Award $0 +25K $0.00 25K Jan 24, 2022 Common Stock 25K $0.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on January 24, 2022. Twenty-five percent (25%) of the stock option vests and becomes exercisable on January 24, 2023 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.